Dr.Evidence and MedShr join forces to empower physicians and HCPs with real-time access to the universe of published medical literature and real-world data
SANTA MONICA, Calif., December 08, 2021--(BUSINESS WIRE)--Dr.Evidence™, the leading medical intelligence platform for life sciences companies, today announced the launch of a partnership with MedShr™, the world’s leading clinical case discussion platform.
Putting Knowledge into the Hands of Physicians and HCPs
The partnership integrates Dr.Evidence’s AI-powered DocSearch medical search engine with the MedShr platform for physicians, HCPs, medical societies, and academics. MedShr was developed to enable physicians to share and discuss clinical cases, and connects nearly two million physicians and HCPs in 195 countries for medical learning.
"We are excited about the power that DocSearch puts in the hands of physicians to engage with the published evidence. The real time AI insights and analysis from DocSearch combined with MedShr case discussion and peer-to-peer learning will have a tremendous impact on clinical practice and patient care," said MedShr Founder and CEO Asif Qasim, MA PhD FRCP.
DocSearch generates evidence-based results from medical search queries by processing global published medical literature and real-world data, utilizing powerful, natural language processing and machine learning technology. Physicians and HCPs on MedShr’s platform will be able to leverage this technology to view co-occurring terms across the available body of literature, enabling them to better understand biomedical relationships, from disease symptoms to drug-adverse events, and beyond. The insights gained will both inform and transform interventions for better patient health outcomes.
"Since the beginning, our vision has been to democratize medical evidence," said Dr.Evidence CEO Bob Battista, MBA, FRSPH, FRCP Edinburgh. "That starts with getting medical evidence into the hands of physicians and HCPs who interact daily with peers and directly with patients. Combining the power of the DocSearch specialized medical search engine with the expansive reach of MedShr’s HCP-facing platform creates an unprecedented opportunity for putting actionable insights into the hands of physicians and HCPs, and, in turn, helping them deliver better, evidence-based patient care."
"While Dr.Evidence maintains a strong position in the pharmaceutical and life sciences sectors, this marks our first significant expansion into clinical decision support for physicians," stated Joseph A. Boystak, Chairman of Dr.Evidence. "Medical knowledge is rapidly accelerating in scope and complexity and doubling every several months. The need for an enhanced medical information ecosystem is essential and will be enabled by AI / ML tools such as those offered by Dr.Evidence," Boystak further noted.
Dr.Evidence™ is the leading medical intelligence platform for life sciences companies that enables teams to identify breakthrough insights grounded in the vast universe of published medical information, real-world evidence and proprietary data. It pushes the boundaries of healthcare technology and allows for new possibilities in science, enabling more informed decision making and faster time-to-market for accelerated impact.
MedShr is the world's leading case discussion platform, connecting nearly two million doctors across 195 countries and supporting digital medical education for hundreds of national and specialist medical societies. In addition to the Trinity Challenge, MedShr has won multiple awards for technology, business and impact including Facebook’s Social Good App of the Year 2016, United Nations World Summit Award 2017, ES SME Award in 2018, London Business Award 2020, and Pharma Marketing Award 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005339/en/